Researchers examined if venetoclax—a therapy commonly used in the treatment of acute myelogenous leukemia and chronic lymphocytic leukemia—was associated with an increased risk of opportunistic infections,...
On March 8, the FDA approved the injectable weight loss medication, semaglutide, for reducing the risk of cardiovascular events such as heart attack, stroke, and cardiovascular death in adults with heart...
Researchers evaluated the association between phosphodiesterase type 5 inhibitor initiation compared with nonuse and the risk of developing AD in men with erectile dysfunction.
Researchers examined patterns among individuals who previously used preventative services and vaccinations and later vaccinations for both influenza and COVID-19 among US adults.
Studies have shown that metformin use among individuals with diabetes has been associated with a reduced risk of age-related macular degeneration development. But does this relationship between metformin...
Gynecologic oncologists currently lack risk models that can accurately predict an endometrial cancer diagnosis at the time of hysterectomy for endometrial intraepithelial neoplasia. To fill this gap,...
This COVID-19 roundup includes coverage of the latest and final COVID-19 treatment guidelines by the NIH, the effectiveness of the COVID-19 vaccine in preventing pediatric long COVID, the spring 2024...